Neurocrine Biosciences Inc (NBIX) Price and Market Data

Neurocrine Biosciences Inc is a biopharmaceutical company dedicated to the research, development, and commercialization of therapies for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes treatments for tardive dyskinesia, chorea associated with Huntington’s disease, classic congenital adrenal hyperplasia caused by 21-hydroxylase deficiency, as well as therapies for endometriosis and uterine fibroids. The company also advances a pipeline of drug candidates across clinical and preclinical stages within its core therapeutic areas, spanning small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. Neurocrine Biosciences generates revenue through sales of its pharmaceutical products.